Intervacc is trading down 14.57% at €0.06, with no confirmed company-specific catalyst identified for the October 1, 2026 decline.

  • The latest identified company update was a September 15 announcement that CEO Carl-Johan Dalsgaard would participate in the Swiss Nordic Bio Conference on October 1; it does not establish a reason for the selloff.
  • Broad-market indices were essentially flat in the supplied context, so the decline cannot be confidently attributed to wider market sentiment.